Intellia Therapeutics Inc buy SVB Leerink LLC
Start price
03.03.26
/
50%
€12.16
Target price
03.03.27
€24.79
Performance (%)
-4.24%
Price
11:00
€11.65
Summary
This prediction is currently active. With a performance of -4.24%, the BUY prediction for Intellia Therapeutics Inc by SVB_Leerink_LLC is down slightly. This prediction currently runs until 03.03.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Intellia Therapeutics Inc | -4.24% |
| iShares Core DAX® | -3.809% |
| iShares Nasdaq 100 | 0.487% |
| iShares Nikkei 225® | -4.418% |
| iShares S&P 500 | 0.251% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its price target raised by Leerink Partners from $27.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat